Trending...
- RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
- Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
- Spokane Police are investigating a collision on West Airport Drive
CARTHAGE, Mo. - Washingtoner -- Stratum Nutrition®, (a business of ESM Technologies), and Adare Biome™, (a division of Adare Pharma Solutions) have entered into a value-added distribution agreement for LBiome™, a unique postbiotic composed of 2 human-origin strains that have been heat-stabilized with its culture medium. LBiome™, also known as Lactobacillus LB, has been used as a digestive health solution for over a century. This alliance adds strategic value for both companies within the dietary supplement marketplace.
Researched in postbiotic form for over 100 years, LBiome™ is the "Pioneer in Postbiotics", with 18 published clinical studies showing digestive health support for both adult and pediatric populations. LBiome™ provides the digestive benefits of a probiotic and the formulation flexibility of a spore, with none of the stability or manufacturing concerns.
Studies have shown that LBiome™ cells adhere to intestinal epithelial cells (the type of cells that line the gut) and strengthen the connections (tight junctions) between these cells. LBiome™ has been shown to rapidly calm lower GI upset as evidenced in the many published clinical studies that have demonstrated the beneficial effects of LBiome™.
More on Washingtoner
"Postbiotics are an emerging category of biotics in the microbiome space, having shown very interesting properties and benefits in which Adare Biome has an expertise as an organization in that area", said Frederic Appert, Vice President & Business Unit Leader at Adare Biome. "We are excited to be partnering with Stratum Nutrition to make our technology available in the US dietary supplement market."
Micah Osborne, President of Stratum Nutrition said, "It is exciting to enter the digestive health category by bringing a unique ingredient for gut health into Stratum's highly selective portfolio. As more customers want alternative delivery options with human-derived strains, we see big opportunities for this health category and look forward to sharing with the industry the efficacy and flexibility of the postbiotic ingredient, LBiome™. It is an honor to partner with Adare, a company with a legacy of developing and manufacturing innovative products of the highest integrity."
For more information about Stratum Nutrition and its branded ingredients, please email info@StratumNutrition.com.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
More on Washingtoner
About Adare Biome
Adare Biome is a division of Adare Pharma Solutions focused on postbiotic production through a proprietary ECHO™ fermentation process. Adare Biome operates from Houdan, France, a GMP Drug facility for microbial fermentation. Adare Biome's activity is to develop, produce, and commercialize microbiological products including its pharmaceutical product Lactéol™, and its ingredient for digestive health applications, LBiome™. Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, development, and manufacturing. To learn more visit www.adarepharmasolutions.com.
Researched in postbiotic form for over 100 years, LBiome™ is the "Pioneer in Postbiotics", with 18 published clinical studies showing digestive health support for both adult and pediatric populations. LBiome™ provides the digestive benefits of a probiotic and the formulation flexibility of a spore, with none of the stability or manufacturing concerns.
Studies have shown that LBiome™ cells adhere to intestinal epithelial cells (the type of cells that line the gut) and strengthen the connections (tight junctions) between these cells. LBiome™ has been shown to rapidly calm lower GI upset as evidenced in the many published clinical studies that have demonstrated the beneficial effects of LBiome™.
More on Washingtoner
- Inside-Out Hollywood: The Relentless Rise of Joseph Nybyk (AKA Joseph Neibich)
- Lumetra Launches Engram, an MCP-Native Memory Layer Scoring 91.6% on LongMemEval
- Spokane Parks & Recreation's Therapeutic Recreation Receives Donation
- SRK Collective Media Group Launches with a Modern Approach to Media, Authority Building, and Cultural Visibility
- MSBG Corporation Acquires GridWatch US Telemetry Automation System
"Postbiotics are an emerging category of biotics in the microbiome space, having shown very interesting properties and benefits in which Adare Biome has an expertise as an organization in that area", said Frederic Appert, Vice President & Business Unit Leader at Adare Biome. "We are excited to be partnering with Stratum Nutrition to make our technology available in the US dietary supplement market."
Micah Osborne, President of Stratum Nutrition said, "It is exciting to enter the digestive health category by bringing a unique ingredient for gut health into Stratum's highly selective portfolio. As more customers want alternative delivery options with human-derived strains, we see big opportunities for this health category and look forward to sharing with the industry the efficacy and flexibility of the postbiotic ingredient, LBiome™. It is an honor to partner with Adare, a company with a legacy of developing and manufacturing innovative products of the highest integrity."
For more information about Stratum Nutrition and its branded ingredients, please email info@StratumNutrition.com.
###
About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.
More on Washingtoner
- TAYP Expands Athlete Exposure Platform Beyond Georgia With New Push Into Virginia and the 757
- KT Medical Staffing Expands Concierge Nursing and Private Duty Nursing Services in Orange County
- The Millennium Alliance Achieves Great Place To Work® Certification™ Amid Continued Growth
- The Millennium Alliance Appoints Former Adweek Executive Eric Hayden Shakun as Chief Financial Officer to Accelerate Next Phase of Growth
- North Puget Sound League Launches New Player Development Academy (PDA) Tryouts
About Adare Biome
Adare Biome is a division of Adare Pharma Solutions focused on postbiotic production through a proprietary ECHO™ fermentation process. Adare Biome operates from Houdan, France, a GMP Drug facility for microbial fermentation. Adare Biome's activity is to develop, produce, and commercialize microbiological products including its pharmaceutical product Lactéol™, and its ingredient for digestive health applications, LBiome™. Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, development, and manufacturing. To learn more visit www.adarepharmasolutions.com.
Source: Stratum Nutrition
0 Comments
Latest on Washingtoner
- KLEKT Announces Appointment of Jay Kimpton to Board of Directors
- Michigan Attorney General Closed FGM Licensing Investigations Months Before Federal Case Ended, Records Show
- Mensa Foundation Event Reframes Brain Health for Every Age
- DLT Resolution, Inc. (Stock Symbol: DLTI) Expands Into the $224 Billion Life Settlements Market While Accelerating Telecom Growth Across Canada
- Ashley Wineland's 'Love + Heartbreak' Tour Brings her Emotional and Empowering Album 'Wineland' to Nationwide Audiences
- Tacoma City Council Restricts Unauthorized Use of Public Property for Civil Immigration Enforcement
- Spokane Police investigate shooting in north Spokane and make an arrest
- People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
- Tacoma: City Manager Hyun Kim Details 'Roadmap to Recovery' Addressing the City's General Fund Deficit and Modernizing City Operations
- With a Dream and a Team, Monalisa Okojie Is Empowering the Next Generation Through EXPOSE NGO
- Spokane: DUI Driver Taken Into Custody After Attempting to Flee from Officers
- Tacoma Police Department to Recognize Five Tacoma Public School Employees Who Intervened in Violent Assault
- American Properties Realty, Inc. Celebrates 2026 FAME Awards - Community of the Year - Heritage at South Brunswick
- Spokane City Council Approves Activation of Public Spaces Program
- Mel Blackwell to Keynote 2026 NSSF Marketing and Leadership Summit
- SmartCone and Samsung Launch RoadDefender™ to Enhance Real-Time Safety for Roadside Workers
- The Personal Development Industry Has a Blind Spot Says Global Personal Success Guru Omar L. Harris
- Kevin "Mr. Wonderful" O'Leary Begins New Universal Coin & Bullion Promotion of Gold and Silver
- Flamingo Compliance Launches Schengen Area Trip Planning Tools as New Digital Border Controls Take Effect
- HHS Announces Major Push to Address Psychiatric Drug Risks: CCHR Applauds Focus on Informed Consent and Safe Tapering
